GlobeStar Therapeutics Other Current Liabilities

GlobeStar Therapeutics's other current liabilities stands at $960K as of June 2024. That compares with $41K in the prior-year period — up 2262.2% year over year. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.

GlobeStar Therapeutics reported $960K in other current liabilities versus $41K a year earlier — a 2262.2% year-over-year increase. The historical chart on this page makes it easier to see whether that move is part of a longer pattern.

That compares with $41K in the prior-year period — up 2262.2% year over year. Sustained growth in other current liabilities can support a stronger franchise, while sharp declines may reflect divestitures, weaker demand, or accounting changes. Always read YoY moves with the footnotes of recent filings in mind.

The history chart shows how GlobeStar Therapeutics's other current liabilities evolved across reporting periods, while the comparison chart places GSTC next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.

Yes — within Industrials, other current liabilities is commonly used to spot outliers. GlobeStar Therapeutics's reading of $960K is a starting point; confirm whether differences come from growth, margins, accounting choices, or one-time items before treating an outlier as a buy or sell signal.